Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Boston, Massachusetts 02115


Purpose:

The researchers hypothesize that the addition of nesiritide to standard therapy will prevent worsening of renal function in patients admitted to the hospital with decompensated heart failure and renal dysfunction relative to standard therapy alone.


Criteria:

Inclusion Criteria: - Decompensated heart failure hospitalization with at least 1 symptom and 1 sign of elevated filling pressures - Admission estimated creatinine clearance =< 50 cc/min. Exclusion Criteria: - Systolic blood pressure < 85 mm Hg - Cardiogenic shock - Volume depletion - Myocardial infarction, unstable angina within last 30 days - Significant valvular stenosis, hypertrophic/restrictive cardiomyopathy, or constrictive pericarditis - Chronic hemodialysis - Anticipated major procedure during hospitalization i.e. left heart catheterization, surgery, or transplantation - Enrolled in another research protocol within last 30 days.


NCT ID:

NCT00119691


Primary Contact:

Principal Investigator
Anju Nohria, MD
Brigham and Women's Hospital


Backup Contact:

N/A


Location Contact:

Boston, Massachusetts 02115
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 15, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.